Skip to content
PharmaManufacturingIQ

Making feasibility more reliable in clinical trials

Muriel Berthier and Denis McMillan, PAREXEL, discuss the key factors for achieving more reliable feasibility in clinical trials

By PharmaManufacturing IQ Staff
Making feasibility more reliable in clinical trials
Published: | 3 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

Muriel Berthier and Denis McMillan, PAREXEL, discuss the key factors for achieving more reliable feasibility in clinical trials

Muriel Berthier and Denis McMillan, PAREXEL

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information